Jayamas Medica Industri TBK PT
IDX:OMED
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
173
222
|
Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Cash Flow Statement
Cash Flow Statement
Jayamas Medica Industri TBK PT
Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | |||||||||
Cash Taxes Paid |
(135 081)
|
(132 656)
|
(146 413)
|
(163 259)
|
(76 907)
|
(64 943)
|
(15 608)
|
(16 870)
|
|
Cash Interest Paid |
(16 952)
|
(16 947)
|
(25 291)
|
(25 421)
|
(16 957)
|
(21 128)
|
(17 272)
|
(17 314)
|
|
Change in Working Capital |
(219 769)
|
(231 549)
|
(333 642)
|
(381 601)
|
(251 415)
|
(250 436)
|
(215 957)
|
(227 772)
|
|
Cash from Operating Activities |
92 617
N/A
|
(36 795)
N/A
|
(25 608)
+30%
|
68 627
N/A
|
134 354
+96%
|
309 431
+130%
|
410 472
+33%
|
393 866
-4%
|
|
Investing Cash Flow | |||||||||
Capital Expenditures |
(75 371)
|
(91 373)
|
(146 675)
|
(181 611)
|
(156 442)
|
(160 036)
|
(127 031)
|
(107 080)
|
|
Other Items |
(419 729)
|
241 766
|
167 061
|
159 412
|
421 035
|
(68 088)
|
(47 353)
|
(29 074)
|
|
Cash from Investing Activities |
(495 100)
N/A
|
150 393
N/A
|
20 386
-86%
|
(22 199)
N/A
|
264 594
N/A
|
(228 124)
N/A
|
(174 384)
+24%
|
(136 155)
+22%
|
|
Financing Cash Flow | |||||||||
Net Issuance of Debt |
744 236
|
753 992
|
753 174
|
753 575
|
(25 307)
|
(35 064)
|
(34 773)
|
(37 583)
|
|
Cash Paid for Dividends |
(250 000)
|
0
|
(335 777)
|
(335 777)
|
(85 777)
|
0
|
0
|
(77 929)
|
|
Other |
(750)
|
0
|
(245)
|
(245)
|
505
|
0
|
0
|
0
|
|
Cash from Financing Activities |
493 486
N/A
|
503 242
+2%
|
417 152
-17%
|
417 554
+0%
|
(110 578)
N/A
|
(120 336)
-9%
|
(34 773)
+71%
|
(115 512)
-232%
|
|
Change in Cash | |||||||||
Effect of Foreign Exchange Rates |
6 704
|
382
|
(2 347)
|
2 719
|
1 654
|
7 504
|
17 748
|
(4 174)
|
|
Net Change in Cash |
97 708
N/A
|
617 221
+532%
|
409 582
-34%
|
466 700
+14%
|
290 023
-38%
|
(31 525)
N/A
|
219 063
N/A
|
138 025
-37%
|
|
Free Cash Flow | |||||||||
Free Cash Flow |
17 247
N/A
|
(128 169)
N/A
|
(172 284)
-34%
|
(112 984)
+34%
|
(22 087)
+80%
|
149 396
N/A
|
283 441
+90%
|
286 786
+1%
|